CliffBio
small molecule

ESKALITH

LITHIUM CARBONATE

Loss of exclusivity—loss of exclusivity
CompanyNoven Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameESKALITH
Active ingredientLITHIUM CARBONATE
Strength300MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Noven Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.